非妇科细胞病理报告系统中恶性肿瘤风险(ROM)的局限性与临床应用再审视
该文讨论甲状腺、唾液腺等常用非妇科细胞病理报告系统中恶性肿瘤风险(ROM)估计的现状。作者指出ROM基于回顾性文献、患者异质且存在偏倚,作为检测后概率受患病率影响,其临床效用值得重新审视。
要点
- 非妇科细胞病理报告系统的ROM多源于回顾性文献,患者群体异质且存在显著偏倚。
- ROM是检测后概率,随检测结果和个体实践场景中恶性肿瘤患病率变化。
- ROM在非妇科细胞病理报告系统中的临床效用受到质疑,需重新评估。
核心结论
- 非妇科细胞病理报告系统中ROM的临床效用受到质疑,可能需要重新审视。
研究设计与样本
- 本文为针对常用非妇科细胞病理报告系统ROM估计现状的讨论性文章,非原始研究。
主要发现
- ROM计算基于对现有文献的回顾性综述,代表异质患者群体,并受显著偏倚和变异困扰。
- ROM代表检测后恶性肿瘤概率,随检测结果及个体实践场景和患者表现的恶性肿瘤患病率(即检测前概率)变化。
临床怎么用
- 临床解读非妇科细胞病理报告系统的ROM时,需考虑其受患病率和检测前概率影响,不宜直接套用。
局限性
- ROM估计基于回顾性文献综述,存在显著偏倚和变异,患者群体异质。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The ever-increasing popularity of standardized systems for reporting cytopathology has led in part to much attention to and importance of the risk stratification schemes, especially the risks of malignancy (ROMs), which are associated with the different diagnostic categories and upon which recommendations for clinical management are based. However, it is well known that the ROM calculations are based on retrospective reviews of the existing literature, representing a heterogeneous patient population, and are plagued by significant biases and variations. Statistically, the ROM represents the post-test probability of malignancy, which changes with the test result and with the prevalence of malignancy (or pretest probability) in an individual practice setting and individual patient presentation. Therefore, the clinical utility of the ROM is questioned and likely needs a second look in the nongynecologic cytopathology reporting systems. In this communication, the authors discuss the status of the ROM estimates according to the most commonly used nongynecologic reporting systems, including for thyroid, salivary glands, and others, highlighting similarities and differences with a focus on the limitations of ROM estimates and their application in clinical practice.
引用
- Pusztaszeri MP, Saieg M, Baloch ZW, et al. Risks of malignancy in the major nongynecologic cytopathology reporting systems: Critiques and discussions. Cancer Cytopathol. 2024. PMID: 38552002. doi:10.1002/cncy.22809
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。